Balantidiasis Market 2018 - Key Vendors are Pfizer (U.S.), Abbott (U.S.), GlaxoSmithKline plc. (U.K), BD (U.S.) and more.

Balantidiasis Market is expected to grow at a CAGR of 2.1% during the forecast period. The global balantidiasis market is segmented on the basis of diagnosis, treatment, and end user. On the basis of diagnosis, the market is segmented into stool examination, sigmoidoscopy, biopsy, and others. On the basis of treatment, the market is segmented into antibiotics, appendectomy, and others. Antibiotics segment is further divided into tetracycline, metronidazole, and others. On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, and others.

Key Players in the Global Balantidiasis Market:

Some of the key players in this market are Pfizer (U.S.), Abbott (U.S.), GlaxoSmithKline plc. (U.K), BD (U.S.), Sandoz International GmbH (Germany), Amneal Pharmaceuticals LLC. (U.S.), Akorn, Inc. (U.S.), and PharmaDerm, a division of Fougera Pharmaceuticals Inc. (U.S.).

Access Sample Copy @ https://www.marketresearchfuture.com/sample_request/4725 .

Market Synopsis of the Global Balantidiasis Market:

Balantidiasis, also known as Balantidium coli infection, is a disease caused by intestinal protozoan parasite Balantidium coli.  Being transmitted through the fecal-oral route, a person acquires the disease by ingesting infective cysts from food and water contaminated by feces. The disease mainly affects large intestine. Diarrhea, weight loss, dysentery, abdominal pain, nausea, and vomiting are common symptoms for balantidiasis. The diseases is found to be prevalent in the rural areas of the developed and developing countries due to the contamination of water by the fecal matter of pigs or humans. The best remedy for the prevention of the disease are maintaining proper conditions for clean and safe drinking water. Antibiotics are most widely used for the treatment of balantidiasis.

Rising prevalence of gastrointestinal disorders, increasing number of patients and availability of treatment of balantidiasis drives the growth of the market. Additionally, the lack of hygiene and sanitation in the rural areas of developing countries is one of the many factors which affect the spread of this disease. Furthermore, rising awareness about the diseases transmitted through fecal-oral route influences the market growth. Competition among existing market players restrict the entry of new players.

Regional Analysis of the Global Balantidiasis Market:

The market for balantidiasis is found to be steady in Americas. The disease is less prevalent in North America due to high quality standards, negligible number of cases, and hygienic environment. Furthermore, emphasis on healthy life style and prevention of communicable diseases also influence the growth of the market. The prevalence of the disease is found to the higher rural South America than North American countries.

Get Discount on Balantidiasis Market Report @ https://www.marketresearchfuture.com/check-discount/4725 .

In Europe, the prevalence of balantidiasis is found to be low. Rising importance of hygienic food products and water, rigorous quality checks, rising expenditure on healthcare, and availability of funds boost the growth of the market.

In Asia Pacific, the prevalence of balantidiasis is found increasing steadily as a result of increasing prevalence of colitis, chronic diarrhea, and, deep intestinal ulcerations and poor hygienic conditions in developing countries. The infection is found to be sub clinical leading to the development of diarrhea leading to the perforation of colon. Furthermore, poor healthcare system in developing countries boost the market growth. Furthermore, the burden of gastrointestinal diseases is attributed to an increase in age, high prevalence of H pylori and lifestyle changes with risk factors such as smoking and obesity. According to the data from GLOBOCAN, in 2012, the age-standardized rate (ASR) of incidence for Asia Pacific was 15.8 and mortality was 11.7 per 100,000. According to World Health Organization (WHO), the geriatric population in China in the year 2013 was 22.6 million which is expected to show a massive growth to 90.4 million in 2050.

LIST OF TABLES:

Table 1 Balantidiasis Industry Synopsis, 2017-2023

Table 2 Global Balantidiasis Market Estimates And Forecast, 2017-2023, (USD Million)

Table 3 Global Balantidiasis Market By Region, 2017-2023, (USD Million)

Table 4 Global Balantidiasis Market By Diagnosis, 2017-2023, (USD Million)

Table 5 Global Balantidiasis Market By Treatment, 2017-2023, (USD Million)

Table 6 Global Balantidiasis Market By End Users, 2017-2023, (USD Million)

Table 7 North America Balantidiasis Market By Diagnosis, 2017-2023, (USD Million)

Table 8 North America Balantidiasis Market By Treatment, 2017-2023, (USD Million)

Table 9 North America Balantidiasis Market By End Users, 2017-2023, (USD Million)

And more…

Browse Full Report @ https://www.marketresearchfuture.com/reports/balantidiasis-market-4725 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.